Ponesimod Shown Promising for MRI Outcomes in Relapsing MS
Compared to teriflunomide, ponesimod showed benefit for magnetic resonance imaging (MRI) outcomes in relapsing multiple sclerosis.
MSVirtual2020 (Joint ACTRIMS-ECTRIMS Meeting)
Complete Coverage
Extended-Release Amantadine Improves Walking Speed in Patients With MS
ADS-5102, the extended release capsule form of amantadine, may clinically benefit walking speed in patients with multiple sclerosis.
Amiloride, Fluoxetine, Riluzole Do Not Reduce Atrophy Rates in Secondary Progressive MS
In secondary progressive multiple sclerosis, amiloride, fluoxetine, and rizuole treatments do not translate into long-term reduction in atrophy rates.
CSF UCH-L1 Biomarker Predictive of Long-Term Disease Progression in MS
Baseline levels of ubiquitin C-terminal hydrolase L1 in cerebral spinal fluid may be predictive of long term multiple sclerosis progression.
Eculizumab Reduces Relapse Risk in Neuromyelitis Optica Spectrum Disorder
The terminal complement inhibitor eculizumab reduced the risk of relapse in patients with neuromyelitis optica spectrum disorder (NMOSD).
Ozanimod May Be a Safe Long-Term Treatment for Relapsing MS
Ozanimod may be a safe and well-tolerated treatment for relapsing forms of multiple sclerosis.
SSRIs May Improve Response to First-Line DMT in Relapsing-Remitting MS
Individuals with relapsing-remitting MS who respond suboptimally to DMT may experience improvement with the addition of an SSRI.
Benefits of Remote Digital Neurological Assessment for Patients with MS
The smartphone-based Symbol Digit Modalities Test is a reliable tool for assessment of cognitive function in patients with multiple sclerosis.
Hypertension Onset May Occur Earlier in MS Patients Born After 1965
Researchers analyzed whether hypertension onset occurs at an earlier age in individuals with multiple sclerosis who were born post-1965.
Wahls Elimination Diet Reduces Fatigue and Improves Quality of Life for MS Patients
The Wahls elimination diet had more significant effects on quality of life for individuals with relapsing-remitting multiple sclerosis as compared to the Swank diet.
Efficacy of Ofatumumab Greater than Teriflunomide in Early Relapsing MS
Ofatumumab was found to have greater efficacy than teriflunomide for the treatment of patients with newly diagnosed relapsing multiple sclerosis.
DMTs Most Effective Among Certain Subgroups of Individuals With MS
Effectiveness of disease modifying therapies for multiple sclerosis was shown to be associated with shorter disease duration and lower relapse rate.
Improvements Are Needed to Measure Impact of Pediatric MS
Youths with multiple sclerosis rate activities and participation as more important life domains than disease-related impairments.
Effects of Migraine on Disability and Neurological Function in MS
Among patients with multiple sclerosis, a history of migraine may not be associated with worse disability or neurological function.
iMSMS Findings Offer Insight Into Gut Microbiome Involvement in MS
The International Multiple Sclerosis Microbiome study noted significant multiple sclerosis linked changes in gut microbiota composition and function.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in MSVirtual2020
Loading... 
Loading...